Browse > Article
http://dx.doi.org/10.4062/biomolther.2018.006

Suppressive Effect of 4-Hydroxy-2-(4-Hydroxyphenethyl) Isoindoline-1,3-Dione on Ovalbumin-Induced Allergic Asthma  

Huang, Jin (Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University)
Su, Mingzhi (Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University)
Lee, Bo-Kyung (Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University)
Kim, Mee-Jeong (Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University)
Jung, Jee H. (Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University)
Im, Dong-Soon (Molecular Inflammation Research Center for Aging Intervention (MRCA) and College of Pharmacy, Pusan National University)
Publication Information
Biomolecules & Therapeutics / v.26, no.6, 2018 , pp. 539-545 More about this Journal
Abstract
4-Hydroxy-2-(4-hydroxyphenethyl)isoindoline-1,3-dione (PD1) is a synthetic phthalimide derivative of a marine compound. PD1 has peroxisome proliferator-activated receptor (PPAR) ${\gamma}$ agonistic and anti-inflammatory effects. This study aimed to investigate the effect of PD1 on allergic asthma using rat basophilic leukemia (RBL)-2H3 mast cells and an ovalbumin (OVA)-induced asthma mouse model. In vitro, PD1 suppressed ${\beta}$-hexosaminidase activity in RBL-2H3 cells. In the OVA-induced allergic asthma mouse model, increased inflammatory cells and elevated Th2 and Th1 cytokine levels were observed in bronchoalveolar lavage fluid (BALF) and lung tissue. PD1 administration decreased the numbers of inflammatory cells, especially eosinophils, and reduced the mRNA and protein levels of the Th2 cytokines including interleukin (IL)-4 and IL-13, in BALF and lung tissue. The severity of inflammation and mucin secretion in the lungs of PD1-treated mice was also less. These findings indicate that PD1 could be a potential compound for anti-allergic therapy.
Keywords
PD1; Anti-allergic; Anti-asthma; Ovalbumin; RBL-2H3;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lee, H. S., Kwon, H.-S., Park, D.-E., Woo, Y. D., Kim, H. Y., Kim, H.-R., Cho, S.-H., Min, K.-U., Kang, H.-R. and Chang, Y.-S. (2015) Thalidomide inhibits alternative activation of macrophages in vivo and in vitro: a potential mechanism of anti-asthmatic effect of thalidomide. PLoS ONE 10, e0123094.   DOI
2 Lee, K.-P., Kang, S., Park, S.-J., Choi, Y.-W., Lee, Y.-G. and Im, D.-S. (2013) Anti-allergic and anti-inflammatory effects of bakkenolide B isolated from Petasites japonicus leaves. J. Ethnopharmacol. 148, 890-894.   DOI
3 Lima, L. M., Castro, P., Machado, A. L., Fraga, C. A. M., Lugnier, C., de Moraes, V. L. G. and Barreiro, E. J. (2002) Synthesis and antiinflammatory activity of phthalimide derivatives, designed as new thalidomide analogues. Bioorg. Med. Chem. 10, 3067-3073.   DOI
4 Lloyd, C. M. and Saglani, S. (2013) T cells in asthma: influences of genetics, environment, and T-cell plasticity. J. Allergy Clin. Immunol. 131, 1267-1274.   DOI
5 Majdalawieh, A. and Ro, H.-S. (2010) PPAR${\gamma}$1 and $LXR{\alpha}$ face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1. Nucl. Recept. Signal. 8, e004.
6 Mishra, V., Banga, J. and Silveyra, P. (2017) Oxidative stress and cellular pathways of asthma and inflammation: therapeutic strategies and pharmacological targets. Pharmacol. Ther. 181, 169-182.
7 Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. and Glass, C. K. (1998) The peroxisome proliferator-activated receptor-${\gamma}$ is a negative regulator of macrophage activation. Nature 391, 79-82.   DOI
8 Romagnani, S. (1994) Lymphokine production by human T cells in disease states. Ann. Rev. Immunol. 12, 227-257.   DOI
9 Sharma, U., Kumar, P., Kumar, N. and Singh, B. (2010) Recent advances in the chemistry of phthalimide analogues and their therapeutic potential. Mini Rev. Med. Chem. 10, 678-704.   DOI
10 Spiegelman, B. (1998) PPAR-${\gamma}$: adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507-514.   DOI
11 Su, M., Cao, J., Huang, J., Liu, S., Im, D. S., Yoo, J.-W. and Jung, J. H. (2017) The in vitro and in vivo anti-inflammatory effects of a phthalimide PPAR-${\gamma}$ agonist. Mar. Drugs 15, 7.   DOI
12 Sun, J., Dong, J., Nurahmat, M., Li, M., Abduwaki, M., Luo, Q., Wei, Y. and Lv, Y. (2016) Loki zupa (Luooukezupa) decoction reduced airway inflammation in an OVA-induced asthma mouse model. Chin. Med. 11, 22.   DOI
13 Tournoy, K., Kips, J., Schou, C. and Pauwels, R. (2000) Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin. Exp. Allergy 30, 79-85.   DOI
14 Tyagi, S., Gupta, P., Saini, A. S., Kaushal, C. and Sharma, S. (2011) The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J. Adv. Pharm. Technol. Res. 2, 236-240.   DOI
15 Umetsu, D. T. and DeKruyff, R. H. (1997) Th1 and Th2 CD4+ cells in human allergic diseases. J. Allergy Clin. Immunol. 100, 1-6.   DOI
16 Umetsu, D. T., McIntire, J. J., Akbari, O., Macaubas, C. and DeKruyff, R. H. (2002) Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3, 715-720.   DOI
17 Xiao, B., Su, M., Kim, E. L., Hong, J., Chung, H. Y., Kim, H. S., Yin, J. and Jung, J. H. (2014) Synthesis of PPAR-${\gamma}$ activators inspired by the marine natural product, paecilocin A. Mar. Drugs 12, 926-939.   DOI
18 Alexandre-Moreira, M. S., Takiya, C. M., de Arruda, L. B., Pascarelli, B., Gomes, R. N., Neto, H. C. C. F., Lima, L. M. and Barreiro, E. J. (2005) LASSBio-468: a new achiral thalidomide analogue which modulates TNF-${\alpha}$ and NO production and inhibits endotoxic shock and arthritis in an animal model. Int. Immunopharmacol. 5, 485-494.   DOI
19 Abbas, A. K., Murphy, K. M. and Sher, A. (1996) Functional diversity of helper T lymphocytes. Nature 383, 787-793.   DOI
20 Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M. and Evans, R. M. (2013) PPAR${\gamma}$ signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557   DOI
21 Alvaro, M., Sancha, J., Larramona, H., Lucas, J., Mesa, M., Tabar, A. and Martinez-Canavate, A. (2013) Allergen-specific immunotherapy: update on immunological mechanisms. Allergol. Immunopathol. (Madr.) 41, 265-272.   DOI
22 Bui, T. T., Piao, C. H., Song, C. H., Shin, H. S., Shon, D.-H. and Chai, O. H. (2017) Piper nigrum extract ameliorated allergic inflammation through inhibiting Th2/Th17 responses and mast cells activation. Cell. Immunol. 322, 64-73.   DOI
23 Aoki, H., Mogi, C., Hisada, T., Nakakura, T., Kamide, Y., Ichimonji, I., Tomura, H., Tobo, M., Sato, K. and Tsurumaki, H. (2013) Protonsensing ovarian cancer G protein-coupled receptor 1 on dendritic cells is required for airway responses in a murine asthma model. PLoS ONE 8, e79985.   DOI
24 Aoki, H., Mogi, C. and Okajima, F. (2014) Ionotropic and metabotropic proton-sensing receptors involved in airway inflammation in allergic asthma. Mediators Inflamm. 2014, 712962.
25 Asano, T., Kume, H., Taki, F., Ito, S. and Hasegawa, Y. (2010) Thalidomide attenuates airway hyperresponsiveness and eosinophilic inflammation in a murine model of allergic asthma. Biol. Pharm. Bull. 33, 1028-1032.   DOI
26 Bhat, M. A., Al-Omar, M. A., Ansari, M. A., Zoheir, K. M., Imam, F., Attia, S. M., Bakheet, S. A., Nadeem, A., Korashy, H. M. and Voronkov, A. (2015) Design and synthesis of N-arylphthalimides as inhibitors of glucocorticoid-induced TNF receptor-related protein, proinflammatory mediators, and cytokines in carrageenan-induced lung inflammation. J. Med. Chem. 58, 8850-8867.   DOI
27 Bo, Q.-L., Chen, Y.-H., Yu, Z., Fu, L., Zhou, Y., Zhang, G.-B., Wang, H., Zhang, Z.-H. and Xu, D.-X. (2016) Rosiglitazone pretreatment protects against lipopolysaccharide-induced fetal demise through inhibiting placental inflammation. Mol. Cell. Endocrinol. 423, 51-59.   DOI
28 Cembrzynska-Nowak, M., Szklarz, E., Inglot, A. D. and Teodorczyk-Injeyan, J. A. (1993) Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am. Rev. Respir. Dis. 147, 291-295.   DOI
29 Coffman, R. L., Seymour, B. W., Lebman, D. A., Hiraki, D. D., Christiansen, J. A., Shrader, B., Cherwinski, H. M., Savelkoul, H. F., Finkelman, F. D. and Bond, M. W. (1988) The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102, 5-28.   DOI
30 Cohn, L., Elias, J. A. and Chupp, G. L. (2004) Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789-815.   DOI
31 Curtis, J., Warnock, M., Arraj, S. and Kaltreider, H. (1990) Histologic analysis of an immune response in the lung parenchyma of mice. Angiopathy accompanies inflammatory cell influx. Am. J. Pathol. 137, 689.
32 Foster, P. S., Mould, A. W., Yang, M., Mackenzie, J., Mattes, J., Hogan, S. P., Mahalingam, S., Mckenzie, A. N., Rothenberg, M. E. and Young, I. G. (2001) Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179, 173-181.   DOI
33 D'Agostino, G., La Rana, G., Russo, R., Sasso, O., Iacono, A., Esposito, E., Raso, G. M., Cuzzocrea, S., Verme, J. L. and Piomelli, D. (2007) Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-${\alpha}$ agonist, modulates carrageenan-induced paw edema in mice. J. Pharmacol. Exp. Ther. 322,1137-1143.   DOI
34 Duan, W., Chan, J. H., Wong, C. H., Leung, B. P. and Wong, W. F. (2004) Anti-inflammatory effects of mitogen-activated protein ki-nase kinase inhibitor U0126 in an asthma mouse model. J. Immunol. 172, 7053-7059.   DOI
35 Eom, S. H., Liu, S., Su, M., Noh, T. H., Hong, J., Kim, N. D., Chung, H. Y., Yang, M. H. and Jung, J. H. (2016) Synthesis of phthalimide derivatives as potential PPAR-${\gamma}$ ligands. Mar. Drugs 14, E112.   DOI
36 Girodet, P.-O., Ozier, A., Bara, I., Tunon de Lara, J. M., Marthan, R. and Berger, P. (2011) Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention. Pharmacol. Ther. 130, 325-337.   DOI
37 Hams, E. and Fallon, P. G. (2012) Innate type 2 cells and asthma. Curr. Opin. Pharmacol. 12, 503-509.   DOI
38 Kwak, Y.-G., Song, C. H., Ho, K. Y., Hwang, P. H., Kim, J.-S., Lee, K. S. and Lee, Y. C. (2003) Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 111, 1083-1092.   DOI
39 Hessel, E. M., Van Oosterhout, A., Van Ark, I., Van Esch, B., Hofman, G., Van Loveren, H., Savelkoul, H. and Nijkamp, F. P. (1997) Development of airway hyperresponsiveness is dependent on interferongamma and independent of eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 16, 325-334.   DOI
40 Huang, J., Kang, S., Park, S.-J. and Im, D.-S. (2017) Apelin protects against liver X receptor-mediated steatosis through AMPK and $PPAR{\alpha}$ in human and mouse hepatocytes. Cell Signal. 39, 84-94.   DOI
41 Lee, A.-Y., Kang, S., Park, S.-J., Huang, J. and Im, D.-S. (2016) Antiallergic effect of oroxylin a from Oroxylum indicum using in vivo and in vitro experiments. Biomol. Ther. (Seoul) 24, 283-290.   DOI
42 Lee, B.-K., Park, S.-J., Nam, S.-Y., Kang, S., Hwang, J., Lee, S.-J. and Im, D.-S. (2017) Anti-allergic effects of sesquiterpene lactones from Saussurea costus (Falc.) Lipsch. determined using in vivo and in vitro experiments. J. Ethnopharmacol. 213, 256-261.